Sonodynamic therapy using water-dispersed TiO2-polyethylene glycol compound on glioma cells: comparison of cytotoxic mechanism with photodynamic therapy.
Sonodynamic therapy is expected to be a novel therapeutic strategy for malignant gliomas. The titanium dioxide (TiO(2)) nanoparticle, a photosensitizer, can be activated by ultrasound. In this study, by using water-dispersed TiO(2) nanoparticles, an in vitro comparison was made between the photodynamic and sonodynamic damages on U251 human glioblastoma cell lines. Water-dispersed TiO(2) nanoparticles were constructed by the adsorption of chemically modified polyethylene glycole (PEG) on the TiO(2) surface (TiO(2)/PEG). To evaluate cytotoxicity, U251 monolayer cells were incubated in culture medium including 100 μg/ml of TiO(2)/PEG for 3h and subsequently irradiated by ultraviolet light (5.0 mW/cm(2)) or 1.0MHz ultrasound (1.0 W/cm(2)). Cell survival was estimated by MTT assay 24h after irradiation. In the presence of TiO(2)/PEG, the photodynamic cytotoxic effect was not observed after 20 min of an ultraviolet light exposure, while the sonodynamic cytotoxicity effect was almost proportional to the time of sonication. In addition, photodynamic cytotoxicity of TiO(2)/PEG was almost completely inhibited by radical scavenger, while suppression of the sonodynamic cytotoxic effect was not significant. Results of various fluorescent stains showed that ultrasound-treated cells lost their viability immediately after irradiation, and cell membranes were especially damaged in comparison with ultraviolet-treated cells. These findings showed a potential application of TiO(2)/PEG to sonodynamic therapy as a new treatment of malignant gliomas and suggested that the mechanism of TiO(2)/PEG mediated sonodynamic cytotoxicity differs from that of photodynamic cytotoxicity.
Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Shigeru
S
Yamaguchi
Hiroyuki
H
Kobayashi
Takuhito
T
Narita
Koki
K
Kanehira
Shuji
S
Sonezaki
Nobuki
N
Kudo
Yoshinobu
Y
Kubota
Shunsuke
S
Terasaka
Kiyohiro
K
Houkin
D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D005909:Glioblastoma / Q000473:pathology / Q000628:therapy*; D010778:Photochemotherapy / Q000379:methods*; D011838:Radiation-Sensitizing Agents / Q000737:chemistry / Q000528:radiation effects / Q000627:therapeutic use; D014025:Titanium / Q000737:chemistry* / Q000528:radiation effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D011838:Radiation-Sensitizing Agents; C009495:titanium dioxide; D014025:Titanium